Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 2786 Records) |
| Query Trace: Ovarian cancer[original query] |
|---|
| Germline multigene panel testing of patients with endometrial cancer. Oncology letters 2023 5 25 (6): 216. Jan Kral, Sandra Jelinkova, Petra Zemankova, Michal Vocka, Marianna Borecka, Leona Cerna, Marta Cerna, Lukas Dostalek, Petra Duskova, Lenka Foretova, Ondrej Havranek, Klara Horackova, Milena Hovhannisyan, Stepan Chvojka, Marta Kalousova, Marcela Kosarova, Monika Koudova, Vera Krutilkova, Eva Machackova, Petr Nehasil, Jan Novotny, Barbora Otahalova, Alena Puchmajerova, Marketa Safarikova, Jiri Slama, Viktor Stranecky, Ivan Subrt, Spiros Tavandzis, Michal Zikan, Tomas Zima, Jana Soukupova, Petra Kleiblova, Zdenek Kleibl, Marketa Janato |
| Effect of ERCC1 polymorphisms on the response to platinum-based chemotherapy: A systematic review and meta-analysis based on Asian population. PloS one 2023 5 18 (5): e0284825. Xiaoqing Wu, Wenping Lu, Cuihong Jiang, Dongni Zhang, Weixuan Zhang, Yongjia Cui, Zhili Zhuo, Heting Mei, Ya'nan Wang, Mengfan Zhang, Shuntai Ch |
| Comprehensive Analysis Identifies the PPAR-Targeted Genes Associated with Ovarian Cancer Prognosis and Tumor Microenvironment. PPAR research 2023 5 2023 6637414. Xiao-Fei Leng, Gao-Fa Wang, Hao Yin, Feng Wei, Kang-Kang Zeng, Yi-Qun Zha |
| Optimisation of polygenic risk scores in BRCA1/2 pathogenic variant heterozygotes in epithelial ovarian cancer. Genetics in medicine : official journal of the American College of Medical Genetics 2023 5 100898. Nicola Flaum, John Bowes, Miriam J Smith, Emma J Crosbie, Richard Edmondson, Artitaya Lophatananon, D Gareth Eva |
| Systematic evaluation of the association between a missense variant in XRCC3 gene splicing site and the pathogenesis of ovarian cancer. Bioscience reports 2023 5 . Qiulian Liang, Gongchen Huang, Ping Zhong, Dengting Deng, Lin Yang, Xiangyuan |
| Comparison of PARPi efficacy according to homologous recombination deficiency biomarkers in patients with ovarian cancer: a systematic review and meta-analysis. Chinese clinical oncology 2023 5 . Felipe Batalini, Laercio Lopes DaSilva, Leticia Campoverde, Ana Carolina Marin Comini, Bruno Murad Carvalho, Wilson Nogueira, Hyan Silveira, Brenda J Ernst, Lida A Mi |
| Nuclear receptor co-repressor NCOR2 and its relation to GPER with prognostic impact in ovarian cancer. Journal of cancer research and clinical oncology 2023 5 . Juliane Reichenbach, Patricia Fraungruber, Doris Mayr, Christina Buschmann, Fabian B T Kraus, Nicole Elisabeth Topalov, Anca Chelariu-Raicu, Thomas Kolben, Alexander Burges, Sven Mahner, Mirjana Kessler, Udo Jeschke, Bastian Czogalla, Fabian Trills |
| Whole exome sequencing of low grade serous ovarian carcinoma identifies genomic events associated with clinical outcome. Gynecologic oncology 2023 5 174 157-166. John P Thomson, Robert L Hollis, Juliette van Baal, Narthana Ilenkovan, Michael Churchman, Koen van de Vijver, Frederike Dijk, Alison M Meynert, Clare Bartos, Tzyvia Rye, Ian Croy, Patricia Diana, Mignon van Gent, Helen Creedon, Rachel Nirsimloo, Fiona Nussey, Christianne Lok, C Simon Herrington, Charlie Gourl |
| Diffusion-weighted magnetic resonance imaging for the pre-operative evaluation of epithelial ovarian cancer patients. Gynecologic oncology 2023 5 174 142-147. Zheng Feng, Yi Fu, Ruimin Li, Haiming Li, Jing Lu, Xiaojun Chen, Xingzhu Ju, Xiaohua Wu, Hao W |
| Risk of Syndrome-Associated Cancers Among First-Degree Relatives of Patients With Pancreatic Ductal Adenocarcinoma With Pathogenic or Likely Pathogenic Germline Variants. JAMA oncology 2023 5 . Xuan Chen, Margaret A Meyer, Jennifer L Kemppainen, Masayasu Horibe, Shruti Chandra, Shounak Majumder, Gloria M Petersen, Kari G Ra |
| A New de novo BRCA1 Mutation in a Young Breast Cancer Patient: A Case Report. The application of clinical genetics 2023 5 16 83-87. Amina Scherz, Susanna Stoll, Benno Rothlisberger, Manuela Rabagl |
| Molecular and phenotypic characteristics influencing the degree of cytoreduction in high-grade serous ovarian carcinomas. Cancer medicine 2023 5 . Cecilie Fredvik Torkildsen, Liv Cecilie Vestrheim Thomsen, Ragnar Kvie Sande, Camilla Krakstad, Ingunn Stefansson, Eva Karin Lamark, Stian Knappskog, Line Bjør |
| Multi-Omics Analysis of the Prognostic and Immunological Role of Runt-Related Transcription Factor 3 in Pan-Cancer. Critical reviews in eukaryotic gene expression 2023 5 33 (4): 63-83. Quan Zhou, Dou-Dou Ding, Man Lu, Man-Zhen Z |
| Challenges for clinical application of "TRACEBACK" study: testing of historical Tubo-Ovarian cancer patients for hereditary risk genes. Annals of translational medicine 2023 5 11 (8): 295. Masayuki Sekine, Masanori Isobe, Koji Nishino, Sosuke Adachi, Kazuaki Suda, Kosuke Yoshiha |
| The CFTR Gene Germline Heterozygous Pathogenic Variants in Russian Patients with Malignant Neoplasms and Healthy Carriers: 11,800 WGS Results. International journal of molecular sciences 2023 5 24 (9): . Maria Makarova, Marina Nemtsova, Anastasiia Danishevich, Denis Chernevskiy, Maxim Belenikin, Anastasiia Krinitsina, Elena Baranova, Olesya Sagaydak, Maria Vorontsova, Igor Khatkov, Lyudmila Zhukova, Natalia Bodunova, Sergey Nikolaev, Mariya Byakhova, Anna Semenova, Vsevolod Galkin, Saida Gadzhie |
| PALB2 germline mutations in a large cohort of Middle Eastern breast-ovarian cancer patients. Scientific reports 2023 5 13 (1): 7666. Abdul K Siraj, Rong Bu, Sandeep Kumar Parvathareddy, Kaleem Iqbal, Saud Azam, Zeeshan Qadri, Maha Al-Rasheed, Wael Haqawi, Mark Diaz, Ingrid G Victoria, Ismail A Al-Badawi, Asma Tulbah, Fouad Al-Dayel, Dahish Ajarim, Khawla S Al-Kura |
| Distinct histopathological features are associated with molecular subtypes and outcome in low grade serous ovarian carcinoma. Scientific reports 2023 5 13 (1): 7681. Robert L Hollis, John P Thomson, Juliette van Baal, Narthana Ilenkovan, Michael Churchman, Koen van de Vijver, Frederike Dijk, Alison M Meynert, Clare Bartos, Tzyvia Rye, Ian Croy, Patricia Diana, Mignon van Gent, Helen Creedon, Rachel Nirsimloo, Christianne Lok, Charlie Gourley, C Simon Herringt |
| Developing four cuproptosis-related lncRNAs signature to predict prognosis and immune activity in ovarian cancer. Journal of ovarian research 2023 4 16 (1): 88. Li Liu, Qing Wang, Jia-Yun Zhou, Bei Zha |
| Genetic Characterization of Ovarian Tumor Tissues from Patients with Epithelial Ovarian Cancer in a Philippine Tertiary Hospital: A Descriptive Study. Asian Pacific journal of cancer prevention : APJCP 2023 4 24 (4): 1187-1197. Ryan C V Lintao, Ana Joy P Padua, Yukiko Nakura, Erlidia F Llamas-Clark, Itaru Yanagiha |
| Ovarian Cancer and Parkinson's Disease: A Bidirectional Mendelian Randomization Study. Journal of clinical medicine 2023 4 12 (8): . Jian-Zeng Guo, Qian Xiao, Lang Wu, Fa Chen, Jia-Li Yin, Xue Qin, Ting-Ting Gong, Qi-Jun |
| T-Cell Receptor Repertoire Characteristics Associated with Prognostic Significance in High-Grade Serous Ovarian Carcinoma. Genes 2023 4 14 (4): . Ju-Won Kim, Sewha Kim, So-Yun Yang, Je-Gun Joung, Sohyun Hwa |
| Aberrant serum and tissue levels of Beclin1 and mechanistic target of rapamycin (mTOR) proteins in epithelial ovarian cancer. Medicine 2023 4 102 (17): e33515. Huixia Lu, Hong Hu, Zhihong Yang, Shaobo |
| Somatic Variants in DNA Damage Response Genes in Ovarian Cancer Patients Using Whole-exome Sequencing. Anticancer research 2023 4 43 (5): 1891-1900. Joanna Lopacinska-Joergensen, Douglas V N P Oliveira, Tim Svenstrup Poulsen, Claus K Hoegdall, Estrid V Hoegda |
| Comprehensive Genomic Profiling Detects Hereditary Cancers and Confers Survival Advantage in Patients With Gynaecological Cancers. Anticancer research 2023 4 43 (5): 2091-2101. Tomoko Ueda, Hiroshi Tsubamoto, Yumi Takimoto, Roze Isono-Taniguchi, Sachiyo Narita, Kohei Nakagawa, Y U Wakimoto, Yumiko Nishimura, Yoshiko Muroi, Masayuki Nagahashi, Seiichi Hirota, Hideaki Sawai, Hiroaki Shibaha |
| Multi-omics analysis of the Indian ovarian cancer cohort revealed histotype-specific mutation and gene expression patterns. Frontiers in genetics 2023 4 14 1102114. Anisha Mhatre, Jinsha Koroth, Meghana Manjunath, Sandeep Kumar S, Ramesh Gawari, Bibha Choudha |
| The association between TIPARP gene polymorphisms rs2665390 and ovarian cancer susceptibility. Gynecologic oncology reports 2023 4 47 101175. Maryam Vahidi, Massoud Houshmand, Mahdieh Banoei, Farid Heida |
| The association between age at breast cancer diagnosis and prevalence of pathogenic variants. Breast cancer research and treatment 2023 4 . Mary B Daly, Eric Rosenthal, Shelly Cummings, Ryan Bernhisel, John Kidd, Elisha Hughes, Alexander Gutin, Stephanie Meek, Thomas P Slavin, Allison W Kuri |
| The polymorphism rs4705342 in the promoter of miR-143/145 is related to the risk of epithelial ovarian cancer and patient prognosis. Frontiers in oncology 2023 4 13 1122284. Jian Zhao, Weiwei Zuo, Yue Zhang, Caiyun He, Wei Zhao, Tongyu Me |
| Genetic analysis for mucinous ovarian carcinoma with infiltrative and expansile invasion and mucinous borderline tumor: a retrospective analysis. Diagnostic pathology 2023 4 18 (1): 49. Taira Hada, Morikazu Miyamoto, Yuka Ohtsuka, Jin Suminokura, Tsubasa Ito, Naohisa Kishimoto, Soko Nishitani, Minori Takada, Akari Imauji, Risa Tanabe, Masashi Taka |
| The pathogenic role of the BRCA2 c.7847C>T (p.Ser2616Phe) variant in breast and ovarian cancer predisposition. Cancer science 2023 4 . Yamazawa Kazuki, Sugano Kokichi, Tanakaya Kohji, Inoue Satomi, Murakami Haruka, Nakashima Moeko, Adachi Masataka, Oki Shinya, Makabe Takeshi, Yamashita Hiroshi, Ueki Arisa, Sasaoka Ayako, Nakashoji Ayako, Kinoshita Takayuki, Matsunaga Tatsuo, Arai Masami, Nakamura Seigo, Miyata Hiroaki, Ikegami Masachika, Mano Hiroyuki, Kohsaka Shinji, Matsui Aki |
- Page last reviewed:Feb 1, 2023
- Page last updated:May 22, 2023
- Content source: